Joint pain and menopause: causes and solutions

Why menopause triggers joint pain

Hot flashes get a lot of attention, but joints get less. Yet the studies are clear: in a review published in the journal Maturitas, more than half of women in perimenopause and menopause report arthralgia — joint pain without visible damage. The large American SWAN study, which followed thousands of women during the transition, found joint pain or stiffness in about 6 in 10 women at the end of perimenopause.

The reason is biological, not psychological. Your joints are living tissues, and estrogen plays three protective roles there:

First role: anti-inflammatory. Estrogens inhibit the local production of inflammatory cytokines in the synovial membrane. When estrogen levels drop, low-grade inflammation sets in—hence this diffuse morning stiffness. Second role: trophic. Estradiol stimulates chondrocytes, the cells that produce cartilage, as documented in the research published in Arthritis Research & Therapy. Third role: tissue hydration. Less estrogen means less hyaluronic acid in the synovial fluid—the joint is less “lubricated.”

Recognizing menopausal arthralgia (and not confusing it with osteoarthritis)

This is the question my patients ask me most often during consultations: “Is it osteoarthritis?” Not necessarily. Menopausal hormonal arthralgia has a distinct signature: it is diffuse, symmetrical, and fluctuating. It commonly affects the fingers, wrists, knees, and shoulders—often on both sides—and is more pronounced in the morning, improving with movement.

Osteoarthritis, on the other hand, is localized mechanical wear: one specific joint, with pain that increases with exertion and eases with rest. The two can coexist, but they do not call for the same response.

Joint pain during menopause: solutions that really work

The good news: unlike mechanical wear and tear, hormonal arthralgia responds well to lifestyle changes. Three key factors stand out in the literature.

Collagen, vitamin C, magnesium: what the science says about supplements

Joint tissue is composed mainly of type II collagen (cartilage) and type I collagen (tendons, ligaments). Yet collagen production drops sharply after menopause—with up to 30% of the body's collagen lost in the first five years, according to available dermatological and connective tissue data.

This is where supplementation has a solid rationale. Randomized clinical trials conducted with hydrolyzed collagen peptides show a reduction in activity-related joint pain after 12 weeks of daily use. Once absorbed, collagen peptides provide chondrocytes with the specific amino acids (glycine, proline, hydroxyproline) they need—and appear to stimulate their synthesis activity.

Three cofactors deserve attention:

A note on dosage form: to reach clinically studied doses (5 to 12 g of collagen peptides per day), the liquid form is more practical than capsules—you would need to swallow more than fifteen capsules to get the same dose. This is the choice we made at Nutremys, and it is explained in detail in our complete guide to marine collagen during menopause.

Signs that you may benefit from supplementation

Joint supplementation may be particularly worthwhile if several of these situations apply to you:

• Diffuse morning stiffness that appeared or worsened during perimenopause;
• Symmetrical pain in the fingers, knees, or shoulders, fluctuating from week to week;
• More frequent cracking and popping, with a feeling of “dry” joints;
• Thinner skin and more brittle hair at the same time—signs of an overall collagen deficiency;
• Low dietary intake of protein and oily fish;
• Reduced physical activity due to pain.

In all cases, a medical assessment is necessary if the pain is severe or localized, or accompanied by swelling or redness. For an overview of micronutrients that may be useful during this stage of life, see our guide to essential vitamins during menopause, as well as our complete guide to menopause symptoms.